These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M, Roberts A, Davies S, Rees A. Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [Abstract] [Full Text] [Related]
24. Role of fibric acid derivatives in the management of risk factors for coronary heart disease. Després JP, Lemieux I, Robins SJ. Drugs; 2004; 64(19):2177-98. PubMed ID: 15456334 [Abstract] [Full Text] [Related]
38. Advances in lipid testing and management in patients with diabetes mellitus. Vasudevan MM, Ballantyne CM. Endocr Pract; 2009 Jul; 15(6):641-52. PubMed ID: 19625239 [Abstract] [Full Text] [Related]
39. A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus. Winocour PH, Durrington PN, Bhatnagar D, Mbewu AD, Ishola M, Mackness M, Arrol S. Diabetes Res Clin Pract; 1992 Dec; 18(3):173-84. PubMed ID: 1289018 [Abstract] [Full Text] [Related]
40. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study. García Ruiz FJ, Marín Ibáñez A, Pérez-Jiménez F, Pintó X, Nocea G, Ahumada C, Alemao E, Yin D, REALITY Study Group. Pharmacoeconomics; 2004 Dec; 22 Suppl 3():1-12. PubMed ID: 15669149 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]